arrow
L

Lauren Walker

nihr liverpool clinical research facility
H指数:20
被引数:1,903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An automation framework for clinical codelist development validated with UK data from patients with multiple long-term conditions

一个用于临床码表开发的自动化框架,已使用来自患有多种长期疾病患者的英国数据进行了验证

2025-05-240
OA
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
2023-02-0161
OAAI
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
2022-11-2625
OAAI
Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
2022-03-1015
OAAI
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2
2021-11-1314
OAAI
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite β-d-N4-hydroxycytidine in human plasma and saliva

用于同时定量人血浆和唾液中莫那比拉韦及其代谢物 β-d-n4-羟基胞苷的新型lc-ms/MS方法的开发和验证

2021-11-0153
OAAI
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
2021-08-2783
OAAI